Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
V. Raghavan
Institution:
Roche (Canada)
Observed institutions:
University Health Network,
University of Toronto,
Princess Margaret Cancer Centre,
University of Chicago,
University of Chicago Medical Center,
Roche (Canada)
show all 6
OpenAlex ID:
A5109604864
Combined modality therapy for stage IIIMO non-small cell lung cancer. A five-year experience
1984
·
Patricia J. Madej
, Jacob D. Bitran
, et al.
·
Cancer
·
23
PDF
Accelerated partial breast irradiation using intensity modulated radiotherapy
2004
·
M.A. Lacombe
, J. McMahon
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
5
PDF
Accelerated partial breast irradiation using intensity modulated radiotherapy: Dose-volume histogram comparison with standard breast irradiatio
2004
·
M. A. Lacombe
, W. Al-Najjar
, et al.
·
Journal of Clinical Oncology
·
2
Circulating Tumor Dna (ctdna) Status and Clinical Outcomes in Patients (pts) With Previously Untreated Diffuse Large B‐cell Lymphoma (dlbcl) in the Polarix Study
2023
·
A. F. Herrera
, S. Tracy
, et al.
·
Hematological Oncology
·
1
PDF
OA08.01 Organoid Cultures as Novel Preclinical Models of Non-Small Cell Lung Cancer
2019
·
M. Tsao
, R. Shi
, et al.
·
Journal of Thoracic Oncology
·
1
PDF
MTE01.02 Lung Patient Derived Xenograft and Organoid
2018
·
N. Moghal
, N. Pham
, et al.
·
Journal of Thoracic Oncology
·
1
P2.03-37 Genomic Landscape of EGFR/ALK Wild-Type Lung Adenocarcinomas in Never-Smokers and Importance of Epithelial-Mesenchymal-Transition
2019
·
A. Fares
, S. Martins-Filho
, et al.
·
Journal of Thoracic Oncology
PDF
P2.03-11 Impact of Ethnicity on Outcome in Never Smokers with EGFR and ALK Wildtype (EGFR/ALK-Wildtype) Lung Adenocarcinomas
2019
·
S. Martins-Filho
, A. Fares
, et al.
·
Journal of Thoracic Oncology
MA27.03 Multi-Omic Characterization of TKI-Treated Drug-Tolerant Cell Population in an EGFR-Mutated NSCLC Primary-Derived Xenograft
2018
·
E. Stewart
, M. Cabanero
, et al.
·
Journal of Thoracic Oncology
PDF
MA27.07 Lung Adenocarcinoma Harboring BRAF G469V Mutation is Uniquely Sensitive to EGFR Tyrosine Kinase Inhibitors
2018
·
H. Notsuda
, N. Pham
, et al.
·
Journal of Thoracic Oncology
PDF
P3.03-008 Organoid Cultures of Lung Squamous Cell Carcinoma for Drug Screening
2017
·
R. Shi
, N. Radulovich
, et al.
·
Journal of Thoracic Oncology
PDF
Show more works
View as search
Works count:
11
Citation count:
33
H-index:
2
I10-index:
1
Year
Topic
Type